Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 23
299
Views
7
CrossRef citations to date
0
Altmetric
Short Communication

Inhibition of CDK2/CyclinE1 by xanthones from the mangosteen (Garcinia mangostana): a structure-activity relationship study

, , , &
Pages 5429-5433 | Received 21 Feb 2020, Accepted 24 May 2020, Published online: 21 Jul 2020

References

  • Bartmańska A, Tronina T, Popłoński J, Milczarek M, Filip-Psurska B, Wietrzyk J. 2018. Highly cancer selective antiproliferative activity of natural prenylated flavonoids. Molecules. 23(11):2922–2935.
  • Chin YW, Kinghorn AD. 2008. Structural characterization, biological effects, and synthetic studies on xanthones from mangosteen (garcinia mangostana), a popular botanical dietary supplement. Mini Rev Org Chem. 5(4):355–364.
  • Ding YY, Luan JJ, Fan Y, Olatunji OJ, Song J, Zuo J. 2020. α-Mangostin reduced the viability of A594 cells in vitro by provoking ROS production through downregulation of NAMPT/NAD. Cell Stress Chaperones. 25(1):163–172.
  • Gutierrez-Orozco F, Failla ML. 2013. Biological activities and bioavailability of mangosteen xanthones: a critical review of the current evidence. Nutrients. 5(8):3163–3183.
  • Ibrahim SRM, Abdallah HM, El-Halawany AE, Nafady AM, Mohamed GA. 2019. Mangostanaxanthone VIII, a new xanthone from Garcinia mangostana and its cytotoxic activity. Nat Prod Res. 33 (2):258–265.
  • Johnson JJ, Petiwala SM, Syed DN, Rasmussen JT, Adhami VM, Siddiqui IA, Kohl AM, Mukhtar H. 2012. Alpha-mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth. Carcinogenesis. 33(2):413–419.
  • Kurose H, Shibata MA, Iinuma M, Otsuki Y. 2012. Alterations in cell cycle and induction of apoptotic cell death in breast cancer cells treated with α-mangostin extracted from mangosteen pericarp . J Biomed Biotechnol. 2012:672428.
  • Lee HN, Jang HY, Kim HJ, Shin SA, Choo GS, Park YS, Kim SK, Jung JY. 2016. Antitumor and apoptosis-inducing effects of α-mangostin extracted from the pericarp of the mangosteen fruit (Garcinia mangostana L.)in YD-15 tongue mucoepidermoid carcinoma cells. Int J Mol Med. 37(4):939–948.
  • Li G, Petiwala SM, Yan M, Won JH, Petukhov PA, Johnson JJ. 2016. Gartanin, an isoprenylated xanthone from the mangosteen fruit (garcinia mangostana), is an androgen receptor degradation enhancer. Mol Nutr Food Res. 60(6):1458–1469.
  • Li G, Thomas S, Johnson JJ. 2013. Polyphenols from the mangosteen (garcinia mangostana) fruit for breast and prostate cancer. Front Pharmacol. 4:80.
  • Malumbres M, Barbacid M. 2001. To cycle or not to cycle: A critical decision in cancer. Nat Rev Cancer. 1(3):222–231.
  • Otto T, Sicinski P. 2017. Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer. 17(2):93–115.
  • Pedraza-Chaverri J, Cardenas-Rodriguez N, Orozco-Ibarra M, Perez-Rojas JM. 2008. Medicinal properties of mangosteen (garcinia mangostana). Food Chem Toxicol. 46(10):3227–3239.
  • Petiwala SM, Li G, Ramaiya A, Kumar A, Gill RK, Saksena S, Johnson JJ. 2014. Pharmacokinetic characterization of mangosteen (garcinia mangostana) fruit extract standardized to α-mangostin in C57BL/6 mice . Nutr Res. 34(4):336–345.
  • Pham V, Rendon R, Le VX, Tippin M, Fu DJ, Le TH, Miller M, Agredano E, Cedano J, Zi X. 2020. Gartanin is a novel NEDDylation inhibitor for induction of Skp2 degradation, FBXW2 expression, and autophagy. Mol Carcinog. 59(2):193–201.
  • Preusser M, De Mattos-Arruda L, Thill M, Criscitiello C, Bartsch R, Ruhstaller T, de Azambuja E, Zielinski CC. 2018. Cdk4/6 inhibitors in the treatment of patients with breast cancer: Summary of a multidisciplinary round-table discussion. ESMO Open. 3(5):e000368.
  • Ramaiya A, Li G, Petiwala SM, Johnson JJ. 2012. Single dose oral pharmacokinetic profile of α-mangostin in mice. Curr Drug Targets. 13(14):1698–1704.
  • Spring L, Bardia A, Modi S. 2016. Targeting the cyclin d-cyclin-dependent kinase (cdk) 4/6-retinoblastoma pathway with selective cdk 4/6 inhibitors in hormone receptor-positive breast cancer: Rationale, current status, and future directions. Discov Med. 21(113):65–74.
  • Suthammarak W, Numpraphrut P, Charoensakdi R, Neungton N, Tunrungruangtavee V, Jaisupa N, Charoensak S, Moongkarndi P, Muangpaisan W. 2016. Antioxidant-enhancing property of the polar fraction of mangosteen pericarp extract and evaluation of its safety in humans. Oxid Med Cell Longev. 2016:1293036.
  • Vemu B, Nauman MC, Veenstra JP, Johnson JJ. 2019. Structure activity relationship of xanthones for inhibition of cyclin dependent kinase 4 from mangosteen (garcinia mangostana l.). Int J Nutr. 4(2):38–45.
  • Wang Y, Chen Y, Cheng X, Zhang K, Wang H, Liu B, Wang J. 2018. Design, synthesis and biological evaluation of pyrimidine derivatives as novel cdk2 inhibitors that induce apoptosis and cell cycle arrest in breast cancer cells. Bioorg Med Chem. 26(12):3491–3501.
  • Wang W, Liao Y, Huang X, Tang C, Cai P. 2018. A novel xanthone dimer derivative with antibacterial activity isolated from the bark of Garcinia mangostana. Nat Prod Res. 32 (15):1769–1774.
  • Whittaker SR, Mallinger A, Workman P, Clarke PA. 2017. Inhibitors of cyclin-dependent kinases as cancer therapeutics. Pharmacol Ther. 173:83–105.
  • Zheng Y, Wang H, Yang M, Peng G, Dong TTX, Xu ML, Tsim K. 2018. Prenylated flavonoids from roots of glycyrrhiza uralensis induce differentiation of b16-f10 melanoma cells. Int J Mol Sci. 19(8):2422.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.